P1032 Ileoanal Pouch Salvage Rates with Endoluminal Vacuum Therapy for Early vs. Late Anastomotic Leaks

A Alipouriani,O Lavryk,J Lipman,T Hull,S Steele,D Liska,S Holubar
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1162
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Anastomotic leakage is a dreaded complication after ileal pouch-anal anastomosis (IPAA) that occurs in 5-10% of cases. Endoluminal vacuum (EndoVac) therapy has emerged as a minimally invasive option that promotes healing by applying negative pressure to the associated abscess cavity through the anastomotic defect but is typically applied only to early IPAA leaks. We hypothesized that EndoVac for early compared with late leaks would be associated with a higher pouch survival rate. Methods We retrospectively reviewed the medical records of consecutive patients who developed a pouch anastomotic leak after IPAA and were treated with EndoVac therapy at our institution between 2005-2023. Patients were stratified into early (30 days) and late (>30 days) leaks. Anastomotic healing was defined as complete closure of the leak site, as evidenced by resolution of symptoms, normal endoscopic and radiographic evaluation, and no further drainage from the presacral space or abdominal wall. Pouch failure was defined as a permanent ileostomy or pouch excision. Figures represent frequency (proportion) or median (range). The probability of pouch survival over time was estimated using the Kaplan-Meier method. Results A total of 13 pouch patients underwent EndoVac therapy for leaks by six surgeons (median age, 34 years; 62% male; median body mass index 25.8 kg/m2. Diagnoses: ulcerative colitis (n=11), and familial adenomatous polyposis (n=2). The median time to leak diagnosis was 32 (12- 340) days; of these 6 (46%) were early and 7 (54%) were late. All (100%) patients were diverted at the time of EndoVac therapy, 10 (77%) patients were still diverted, and 3 (23%) were rediverted. Patients underwent a median of 5 EndoVac changes (2-22) over a median duration of 34.5 (21-125) days. After EndoVac therapy, complete/near-complete defect healing occurred in 9 (69%), 1 whom required suturing of a small residual defect. Of those with incomplete healing (n=4), 3 (23%) underwent pouch excision and 1 (7.7%) a redo pouch. Comparing early and late leaks, defect healing (66.7% vs 71.4%, p=0.72) and pouch survival (83.3% vs 71.4%, p=0.65) were similar. The overall pouch salvage rate was 77% (10/13). Conclusion EndoVac therapy is effective for postoperative pouch leaks and achieves a high rate of pouch salvage in both early and late leaks. Figure 1. CONSORT-style flowchart of IPAA leaks treated with EndoVac therapy.
gastroenterology & hepatology
What problem does this paper attempt to address?